title: Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga.
authors.affiliation: UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España; UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España. Electronic address: maroca80@gmail.com.
authors.forename: María del Mar
authors.initials: Mdel M
authors.lastname: Roca-Rodríguez
authors.affiliation: UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España.
authors.forename: María José
authors.initials: MJ
authors.lastname: Tapia-Guerrero
authors.affiliation: UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.
authors.forename: Silvia
authors.initials: S
authors.lastname: Maraver-Selfa
authors.affiliation: UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España; UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España.
authors.forename: Francisco José
authors.initials: FJ
authors.lastname: Tinahones
authors.affiliation: UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.
authors.forename: Isabel
authors.initials: I
authors.lastname: Mancha-Doblas
mesh_terms: D000368:Aged; D000886:Anthropometry; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000188:drug therapy; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D013030:Spain; D000067758:Glucagon-Like Peptide-2 Receptor
chemical_list: D001786:Blood Glucose; D002784:Cholesterol; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008055:Lipids; D010455:Peptides; C479460:lixisenatide; D000067758:Glucagon-Like Peptide-2 Receptor